7210 Wareham Drive, Tampa, FL 33647
Nov. 6, 2025 Weight loss products are a major part of Herbalife’s business, accounting for 55% of total sales for the first nine months of 2025. According to Stephan Gratziani, CEO,… “Herbalife’s third-quarter performance reflects continued progress in our transformation strategy, as well as disciplined financial and operational execution. With North America returning to growth […]
Herbalife Reports 3rd Qtr. Results Read More »
Nov. 4, 2025 Management reported the foillowing: Revenue: $89.4 million, with revenue per active earning coach of $4,585 Active Coaches: Independent active earning OPTA VIA ® coaches of 19,500 Net Loss: $2.3 million or $0.21 loss per diluted share Strong Balance Sheet: $173.5 million in cash, cash equivalents, and investment securities with no debt “We’re transforming Medifast from a
Medifast Reports Q3 Results – Slide Continues Read More »
Oct. 15, 2025 A new Consumer Reports investigation has found that most protein powders and shakes — dietary supplements that have exploded in popularity in recent years — contain more lead in a single serving than is considered safe to ingest in an entire day. Technically, there’s no amount of lead that is considered safe
Study Finds high levels of lead in protein powders, shakes Read More »
August 4, 2025 “We are working diligently to transform our business as we look to help more people achieve optimal metabolic health,” said Dan Chard, CEO of Medifast. “We’re focused on new and impactful ways to reignite coach growth and productivity through targeted initiatives that aim to enhance our offering, expand tailored client solutions, and
Medifast Reports Q2 Results – Slide Continues Read More »
April 30, 2025 Herbalife today reported its first quarter 2025 results. The company sells a significant amount of weight management products (meal replacements), and is one the the leading MLM companies selling weight loss products. At $254.4 million, North American sales represented 20.8% of total Herbalife revenues for the quarter. The company had worldwide weight
Herbalife Reports Q1 2025 Results Read More »
April 2, 2025 Robard, the medical weight loss company, has begun selling its shakes, puddings, soups and beverages direct to the public via a new website. These products are part of its New Direction program. This is a departure from its long-standing policy where you had to sign up for the program to get access
Robard Begins Selling Diet Foods Direct to Consumers Read More »
March 24, 2025 Marketdata LLC has just published a new report: “The U.S. Weight Loss Market: Commercial (non-medical) Programs & Products”, March 2025. This is a 220-page analysis of commercial weight loss programs/companies and how they have been affected by and respond to the onslaught of the GLP-1 drugs competition. The $38 billion U.S. commercial weight loss
$38.4 Billion U.S. Commercial Weight Loss Market Pivots To Survive GLP-1 Drugs Explosion Read More »
March 5, 2025 Weight loss drugs (GLP-1s) have soared in popularity over the last two years, with about 12% of American adults reporting that they’ve used a medication like Ozempic, Wegovy or Mounjaro to slim down. That’s a big slice of the population — and new research shows that being on these medications influences what
GLP-1 Drugs Are Affecting Consumers’ Food Spending Habits Read More »
Feb. 2o, 2025 Herbalife reported Q4 and full year 2024 results. The company sells a significant amount of weight loss and meal replacement products each year. “With three consecutive quarters of new distributor growth, a new incoming CEO and significantly improved Adjusted EBITDA2 margins, we enter 2025 with strong momentum.” – Michael Johnson, Chairman and
Herbalife Reports 2024 Results, $567 Million Weight Loss U.S. Sales Read More »
Feb. 18, 2025 “This past year was a pivotal year for Medifast, as we continued to transform our business to meet the changing nature of a health and wellness market that has been revolutionized by the rising acceptance of GLP-1 medications,” said Dan Chard, Chairman & CEO. Fourth quarter 2024 revenue decreased 37.7% to $119.0
Medifast Reports Q4 and Full Year 2024 Results Read More »